brl 42810 has been researched along with AIDS-Related Opportunistic Infections in 15 studies
AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of 7 days' treatment with famciclovir 500 mg twice a day versus acyclovir 400 mg five times a day, for mucocutaneous herpes simplex virus (HSV) infection in HIV-infected individuals." | 5.09 | Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group. ( Aoki, FY; Lavender, EA; Martel, AY; Parsons, JE; Romanowski, B; Saltzman, RL, 2000) |
| " Herpes virus type 1 and rarely type 2 may lead to painful and resistant oral ulcers, and systemic treatment with acyclovir, valaciclovir or famciclovir is indicated." | 4.79 | Viral lesions of the mouth in HIV-infected patients. ( Itin, PH; Lautenschlager, S, 1997) |
| " Thalidomide (Synovir), developed by Celgene, has received limited approval for the treatment of leprosy." | 3.70 | FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration. ( Highleyman, L, 1998) |
| " The prodrugs valacyclovir and famciclovir offer easier, less-frequent dosing than required for acyclovir." | 2.41 | Progress in meeting today's demands in genital herpes: an overview of current management. ( Patel, R, 2002) |
| " Its bioavailability means that it can be taken less frequently than acyclovir, the only other approved herpes treatment." | 1.29 | Drug effective against herpes. ( , 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattamanchi, A | 1 |
| Saracino, M | 1 |
| Selke, S | 1 |
| Huang, ML | 1 |
| Magaret, A | 1 |
| Celum, C | 1 |
| Corey, L | 2 |
| Wald, A | 1 |
| Casper, C | 1 |
| Patel, R | 1 |
| Danielsen, AG | 1 |
| Petersen, CS | 1 |
| Iversen, J | 1 |
| Ioannidis, J | 2 |
| Wilkinson, D | 2 |
| Itin, PH | 1 |
| Lautenschlager, S | 1 |
| Schacker, T | 1 |
| Hu, HL | 1 |
| Koelle, DM | 1 |
| Zeh, J | 1 |
| Saltzman, R | 1 |
| Boon, R | 1 |
| Shaughnessy, M | 1 |
| Barnum, G | 1 |
| Scoular, A | 1 |
| Barton, S | 1 |
| Breton, G | 1 |
| Bricaire, F | 1 |
| Caumes, E | 1 |
| Romanowski, B | 1 |
| Aoki, FY | 1 |
| Martel, AY | 1 |
| Lavender, EA | 1 |
| Parsons, JE | 1 |
| Saltzman, RL | 1 |
| Highleyman, L | 1 |
| Prescott, LM | 1 |
4 reviews available for brl 42810 and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Progress in meeting today's demands in genital herpes: an overview of current management.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antibodies, V | 2002 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal A | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Age | 2005 |
Viral lesions of the mouth in HIV-infected patients.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus In | 1997 |
3 trials available for brl 42810 and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.
Topics: 2-Aminopurine; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, High | 2011 |
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
Topics: 2-Aminopurine; Adult; Aged; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antiviral Agen | 1998 |
Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
Topics: 2-Aminopurine; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Double-Bli | 2000 |
8 other studies available for brl 42810 and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir.
Topics: 2-Aminopurine; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiviral Agents; Drug | 2002 |
Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, | 1997 |
[Treatment of herpes zoster infections in patients infected with HIV].
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Age | 1999 |
Famciclovir safe and effective for management of shingles.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Fa | 1997 |
Drug effective against herpes.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Famciclovir; Herpes Genitalis; Humans; Recurre | 1996 |
FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; D | 1998 |
Valuable clinical tips from recent medical meetings.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Antiviral Agents; Congresses as Topic; Famcicl | 1999 |
Antiviral drug reduces shedding of herpes virus.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Fa | 1998 |